Medical Health & Life Science Research News

Global postmenopausal osteoporosis drugs market illuminated by new report

Medical Market Research

A brief overview of Global Postmenopausal Osteoporosis Drugs Market in Europe is provided in the report based on product scope and market status & outlook. The market is segmented on the basis of type, end-users/application, and geography

Bones have the ability to grow and heal naturally, but changes in diet, exercise levels, and body chemistry lead to changes in the bone mineral density. This results in osteoporosis, which is characterized by low bone density and structural deterioration of bone tissues, leading to fragile bones.

Rapid bone resorption or slow bone replacement can result in the development of the disease. Gender, age, body size (low body weight), ethnicity, and family history also play a role in developing osteoporosis.

Other risk factors include medication, calcium and vitamin intake, alcohol intake, and smoking.

Report: www.researchbeam.com/global-postme…et/request-sample

Women are at a greater risk of developing osteoporosis than men as estrogens play an important role in maintaining bone strength. Small amounts of bone are lost as part of normal aging process, but on reaching menopause, estrogen levels decline drastically, leading to a greater risk of developing osteoporosis.

Global Postmenopausal Osteoporosis Drugs Market to grow at a CAGR of 4.02% during the period 2016-2020.

Covered in this report 
The report covers the present scenario and the growth prospects of the Global Postmenopausal Osteoporosis Drugs Market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded and generic drugs used to treat and prevent postmenopausal osteoporosis.

The market is divided into the following segments based on geography: 
• Americas
• APAC
• EMEA

Global Postmenopausal Osteoporosis Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years.

The report also includes a discussion of the key vendors operating in this market. 

Key vendors 
• Eli Lilly
• Amgen
• Merck
• Novartis

Report: www.researchbeam.com/global-postme…/purchase-enquiry

Other prominent vendors 
• Allergan
• Amgen Astellas Biopharm 
• Deltanoid Pharmaceuticals
• Noven
• Novo Nordisk
• Osteologix
• Pfizer
• PhytoHealth
• Radius Health
• Tarsa Therapeutics
• UCB
• Uni-Bio Science Group
• Upsher-Smith Laboratories
• Watson Pharmaceuticals
• Zosano Pharma

Market driver 
• Growing prevalence of postmenopausal osteoporosis 
• For a full, detailed list, view our report 

Market challenge 
• Low diagnosis rate
• For a full, detailed list, view our report 

Market trend 
• Emergence of novel agents
• For a full, detailed list, view our report 

Check Full Report with TOC at www.researchbeam.com/global-postme…-2016-2020-market

News From

Research Beam - precise market researchResearch Beam
Category: Market Research Publishers and RetailersCompany about: We have a large database of quality and precise market research reports that will be very beneficial for your organization. Reports that we sell our authentic in nature and from reputed publishers, hence it can definitely help you with your growth opportunities. In order to survive the fierce competition and locate different avenues, one must be privy to high end and quality market information. So, we try and provide you with latest market information by getting high market research reports fro ...
This email address is being protected from spambots. You need JavaScript enabled to view it.